# Safety and Tolerability of VGB-R04 in Patients With Haemophilia B

> **NCT05152732** · EARLY_PHASE1 · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 3 (estimated)

## Conditions studied

- Hemophilia B

## Interventions

- **GENETIC:** VGB-R04

## Key facts

- **NCT ID:** NCT05152732
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-28
- **Primary completion:** 2025-03
- **Final completion:** 2025-12
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05152732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05152732, "Safety and Tolerability of VGB-R04 in Patients With Haemophilia B". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05152732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*